Home > Research

Research Overview

The School of Engineering and UCSD Health Sciences formed the Institute for Engineering in Medicine in 2008 for the integration of engineering principles and novel technologies with biomedical and translational research. Key technology areas include imaging, genotyping-phenotyping, systems biology, medical devices, and nanotechnology. One example is a subcutaneous microdevice that provides continuous glucose monitoring in diabetes and automatically adjusts insulin dosage. The CTRI formally partnered with the new Institute and will serve as its translational research center.

Research in the Institute of Engineering in Medicine focuses on the convergence of disease, technology, and sciences by applying an engineering approach to medicine. The four initial disease focus areas are cancer, cardiovascular diseases, metabolic disorders, and neurodegenerative diseases. The technology areas include imaging, genotypeing-phenotyping, bioinformatics & system biology, medical devices and instrumentation, nanotechnology & nanomedicine, and stem cells.

The IEM establishes new frontiers for research in healthcare by interfacing engineering and biomedical sciences using the team science approach. With active involvement of industry partners and clinical colleagues, the technologies developed in the IEM are effectively transferred to the private sector and healthcare delivery to enhance the health and wellbeing of people.

Partnering with the von Liebig Center for Entrepreneurism and Technology Advancement at UCSD, the IEM will initiate a campus-wide solicitation for Commercialization Grant funding proposals in late 2008.